A Phase II Biomarker-Embedded Study of Lapatinib plus Capecitabine as First-line Therapy in Patients with Advanced or Metastatic Gastric Cancer

Melissa LaBonte Wilson, Dongyun Yang, Peter Wilson, Wu Zhang, Yasir Nagarwala, Kevin Koch, Colleen Briner, Tomomi Kaneko, Sun-Young Rha, Oleg Gladkov, Susan Urba, Dina Sakaeva, Michael Pishvaian, Ruey-Kuen Hsieh, Wei-Ping Lee, Heinz-Josef Lenz